JNJ

Johnson & Johnson (JNJ)

Last Price$159.61.1%
Market Cap$383.4B
LTM ROIC - WACC
4.6%
5Y avg
11.5%
Drug Manufacturers - General industry median
5.7%
Stock quality & Intrinsic value
6/10
0.2% undervalued

Johnson & Johnson ROIC - WACC

Annual
Quarterly
LTM
Industry median
Company stand-alone
JNJ
Healthcare
Crunching data... Almost there!
Jan'05Jan'06Dec'06Dec'07Dec'08Jan'10Jan'11Jan'12Dec'12Dec'13Dec'14Jan'16Jan'17Dec'17Dec'18Dec'19Jan'21Jan'22Jan'23Dec'23
ROIC - WACC
25.1%
30.0%
19.5%
23.2%
16.0%
14.7%
12.0%
17.6%
10.2%
11.3%
11.6%
10.0%
13.8%
(7.1%)
5.9%
6.7%
9.0%
11.6%
11.7%
13.6%
JNJ
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for JNJ and see if it's the right time to invest.
Dive in

Johnson & Johnson (JNJ) ROIC - WACC comparison analysis

Crunching data... Almost there!

JNJ key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is Johnson & Johnson's ROIC - WACC?

As of today, Microsoft Corp's last 12-month ROIC - WACC is 4.6%, based on the financial report for Dec 29, 2024 (Q4 2024). The average annual ROIC - WACC for Johnson & Johnson have been 11.2% over the past three years, and 12.1% over the past five years.

2) Is Johnson & Johnson's ROIC - WACC Good?

As of today, Johnson & Johnson's ROIC - WACC is 4.6%, which is lower than industry median of 5.7%. It indicates that Johnson & Johnson's ROIC - WACC is Bad.

3) How does Johnson & Johnson's ROIC - WACC compare to its peers?

As of today, Johnson & Johnson's ROIC - WACC is 4.6%, which is lower than peer median of 5.6%. The list of peers includes LLY, GILD, NVS, PFE, BMY, AMGN, ABBV, SNY, MRK, AZN.